Can I Take Ashwagandha With Viagra (Sildenafil)?

At a glance
- Interaction class / pharmacodynamic (additive hypotension), no pharmacokinetic data confirmed in humans
- Sildenafil mechanism / PDE5 inhibition raises cGMP, dilates penile and systemic vasculature
- Ashwagandha blood-pressure effect / a 2019 RCT (N=60) showed systolic BP reduction vs. Placebo [1]
- Ashwagandha testosterone effect / a 2019 RCT (N=43) showed 14.7% serum testosterone increase [2]
- Cortisol reduction / a 2012 RCT (N=64) showed 27.9% serum cortisol reduction with KSM-66 [3]
- CYP3A4 concern / ashwagandha withanolides show in-vitro CYP3A4 inhibition, human PK data lacking [4]
- Sildenafil starting dose / 50 mg orally 30 to 60 min before sexual activity (FDA label)
- Key monitoring targets / sitting BP before and 60 min after first combined dose
- Who should avoid co-use / patients on nitrates, alpha-blockers, or with baseline hypotension
What Is the Interaction Between Ashwagandha and Sildenafil?
The interaction is primarily pharmacodynamic rather than pharmacokinetic, meaning the two agents produce overlapping physiological effects rather than altering each other's drug levels in blood. Sildenafil blocks phosphodiesterase-5 (PDE5), raising cyclic guanosine monophosphate (cGMP) and relaxing smooth muscle in penile arteries and, to a lesser extent, systemic vasculature. Ashwagandha (Withania somnifera) independently lowers blood pressure through a mechanism tied to its cortisol-reducing and adaptogenic properties. When both agents lower blood pressure simultaneously, the drop may exceed what either compound produces alone.
No published human pharmacokinetic trial has measured how ashwagandha changes sildenafil plasma concentrations directly. That absence of data does not mean the combination is safe. It means the safety envelope is unknown.
How Sildenafil Affects Blood Pressure
Sildenafil's FDA-approved prescribing information notes mean maximum decreases of 8.4 mmHg systolic and 5.5 mmHg diastolic in healthy volunteers at 100 mg. These numbers increase substantially when sildenafil is combined with antihypertensives or vasodilators. The FDA label explicitly contraindicates co-use with organic nitrates because the combined hypotension can be severe and life-threatening [5].
How Ashwagandha Affects Blood Pressure
A 2019 double-blind RCT published in Medicine (N=60) found that 240 mg/day of ashwagandha root extract for 60 days produced statistically significant reductions in systolic blood pressure compared with placebo [1]. The reduction was modest on its own, averaging roughly 4 to 5 mmHg systolic. Added to sildenafil's 8.4 mmHg reduction, however, the arithmetic places some patients below 90 mmHg systolic, which qualifies as symptomatic hypotension.
The CYP3A4 Question
Sildenafil is metabolized primarily by hepatic CYP3A4 and secondarily by CYP2C9 [5]. In-vitro studies show that withanolides, the primary active constituents of ashwagandha, inhibit CYP3A4 activity [4]. If that inhibition translates to humans at clinically used doses, ashwagandha could raise sildenafil plasma concentrations, prolonging and amplifying both its intended effect and its blood-pressure-lowering side effect. A 2019 pharmacognosy review published in the Journal of Ethnopharmacology identified this concern formally, though the authors noted that in-vitro IC50 values do not reliably predict in-vivo CYP inhibition without dedicated clinical pharmacology studies [4].
What Does Ashwagandha Actually Do to Hormones and Why Does That Matter for ED?
Erectile dysfunction often has a hormonal component. Low testosterone and elevated cortisol both reduce libido and erectile quality. Ashwagandha addresses both of those substrates.
Testosterone
A 2019 double-blind RCT in Medicine (N=43) assigned men with low testosterone to 600 mg/day KSM-66 ashwagandha extract or placebo for eight weeks. Serum testosterone rose by 14.7% in the ashwagandha group compared with 2.6% in the placebo group (P<0.001) [2]. Whether a testosterone increase of that magnitude produces clinically meaningful improvements in erection quality without a PDE5 inhibitor has not been tested in a dedicated trial.
Cortisol
Chronic cortisol elevation suppresses the hypothalamic-pituitary-gonadal axis, reducing testosterone and impairing nitric oxide synthesis in endothelial cells. A 2012 double-blind RCT in the Indian Journal of Psychological Medicine (N=64) found that 300 mg twice daily of KSM-66 ashwagandha root extract reduced serum cortisol by 27.9% vs. Placebo over 60 days (P<0.0001) [3]. That cortisol reduction may indirectly support erectile function through an androgen-mediated pathway distinct from the PDE5 pathway that sildenafil targets.
Thyroid Considerations
Ashwagandha increases serum T3 and T4 in some patients. A 2017 pilot RCT in the Journal of Alternative and Complementary Medicine (N=50) showed significant increases in both thyroid hormones after eight weeks of 600 mg/day ashwagandha [6]. Hyperthyroidism increases cardiac output and can lower peripheral vascular resistance. In a patient already taking sildenafil, an ashwagandha-induced thyroid shift could amplify hemodynamic effects unpredictably. Patients with pre-existing thyroid disease should discuss this risk specifically with their endocrinologist before adding ashwagandha.
Is There Any Clinical Evidence Specifically on the Combination?
No. As of mid-2025, no published randomized controlled trial, cohort study, or pharmacokinetic crossover study has directly evaluated sildenafil co-administered with ashwagandha in humans. The Natural Medicines database (formerly Natural Standard) classifies this combination as having insufficient evidence for a definitive interaction rating, while flagging theoretical concern for additive hypotension [7].
The absence of a direct trial does not place this combination in a low-risk category. It places it in an unknown-risk category. The distinction matters clinically because unknown risk requires active monitoring rather than passive reassurance.
The American Urological Association's 2018 guideline on erectile dysfunction does not specifically address herbal supplement combinations with PDE5 inhibitors, but it does state that prescribers should counsel patients about the hemodynamic risks of PDE5 inhibitors and ask about all concurrent medications and supplements [8].
Practical Risk Stratification: Who Should Be Most Cautious?
Not every patient taking ashwagandha and sildenafil faces the same risk level. Several factors shift the risk profile meaningfully.
Patients at Higher Risk
Anyone already taking an antihypertensive medication, alpha-blocker, or who has a resting systolic BP below 100 mmHg faces additive hypotension risk from any vasodilatory supplement. A 2021 analysis in the Journal of Sexual Medicine noted that among men presenting for ED treatment, roughly 43% had comorbid hypertension and were on at least one antihypertensive agent [9]. Adding ashwagandha to that clinical picture adds another hypotensive variable that is difficult to quantify without a direct pharmacokinetic measurement.
Patients with Cardiac Disease
Sildenafil's label carries a precaution for patients with left ventricular outflow obstruction and those whose cardiac status makes sexual activity inadvisable. Ashwagandha has shown direct cardiac effects in animal models, including reduced heart rate and altered myocardial contractility, though human data at standard supplement doses are limited [10]. Patients with structural heart disease should obtain cardiology clearance before starting either agent.
Lower-Risk Profiles
A healthy man with normal baseline blood pressure (120/80 mmHg), no antihypertensives, and no thyroid disease who takes sildenafil 50 mg and a standard ashwagandha supplement dose (300 to 600 mg/day) faces a theoretically smaller absolute risk. Even so, the first combined dose should be taken under conditions where hypotension (lightheadedness, near-syncope) can be recognized and managed safely. That means sitting or lying down for 60 to 90 minutes after the sildenafil dose rather than immediately engaging in physical activity.
Pharmacokinetic Details: Timing, Dosing, and What the Numbers Look Like
Sildenafil Pharmacokinetics
Sildenafil reaches peak plasma concentration (Cmax) at approximately 30 to 120 minutes after oral dosing. Its half-life is 3 to 5 hours. The FDA label lists 50 mg as the recommended starting dose, adjustable to 25 mg or 100 mg based on efficacy and tolerability [5]. Food with high fat content delays Tmax by up to 60 minutes and reduces Cmax by 29%. Taking ashwagandha with a fatty meal alongside sildenafil would compound timing unpredictability.
Ashwagandha Pharmacokinetics
Ashwagandha withanolides are absorbed within 1 to 2 hours of oral dosing. Clinical trials have used doses ranging from 240 mg/day (single extract dose, Shoden) to 600 mg/day (KSM-66) and 600 to 1,200 mg/day (root powder). There is no established half-life for withanolides in humans that would help define a safe separation window from sildenafil dosing.
Dose-Separation Strategy
Because ashwagandha's effects on cortisol and blood pressure are chronic rather than acute (trials run 8 to 12 weeks to see the full effect), separating the timing of an ashwagandha capsule from a sildenafil dose by 2 to 3 hours provides limited protection. The blood-pressure-lowering effect of ashwagandha is tonic, not acute. If you are taking ashwagandha daily, its effect is always present when you take sildenafil. Dose separation is not a reliable mitigation strategy for the pharmacodynamic interaction.
What to Tell Your Prescriber and How to Monitor
Disclosure
Tell your prescriber every supplement you take. Sildenafil is a Schedule V-equivalent medication with cardiovascular relevance. The American Heart Association's 2021 scientific statement on drug-supplement interactions notes that fewer than 30% of patients voluntarily report supplement use to their physicians, which creates unquantified polypharmacy risk [11]. Your prescriber cannot give you accurate dosing guidance without complete information.
At-Home Blood Pressure Monitoring
If you and your clinician decide to continue both agents after reviewing your cardiovascular risk profile, the practical monitoring protocol is straightforward. Measure your sitting systolic BP before taking sildenafil. Measure again at 60 minutes post-dose. A drop of more than 25 mmHg systolic, or any reading below 90 mmHg systolic accompanied by dizziness, warrants stopping both agents and contacting your prescriber. The threshold of 90 mmHg systolic is the standard hemodynamically significant hypotension cutoff used in emergency medicine [12].
Thyroid Function
If you take ashwagandha long-term (beyond 8 weeks) and have any thyroid symptoms, a TSH measurement provides a useful baseline. A 2017 pilot trial showed TSH decreased alongside increased T3/T4 in patients on 600 mg/day ashwagandha [6]. Subclinical hyperthyroidism changes vascular tone and could amplify sildenafil's hemodynamic effects.
Evidence-Based Alternatives Worth Discussing With Your Provider
Several agents have more direct evidence for ED and carry lower interaction risk with sildenafil than ashwagandha does.
L-citrulline supplementation raises nitric oxide availability through the arginine-NO pathway. A 2011 pilot study in Urology (N=24) showed that 1.5 g/day L-citrulline for one month improved erection hardness scores vs. Placebo, though the sample was small [13]. Citrulline is itself mildly vasodilatory, so the same blood-pressure caution applies if combined with sildenafil, but the mechanism is better characterized.
Zinc at 30 mg/day has been associated with modest testosterone support in deficient men, though a 2020 meta-analysis in the Journal of Trace Elements in Medicine and Biology found effect sizes were small and largely limited to men with confirmed zinc deficiency [14].
Neither of these substitutes ashwagandha's cortisol-modulating effects. The point is that the choice of supplement should follow a discussion with your prescriber about your specific hormonal profile and cardiovascular baseline rather than a general assumption that natural supplements are harmless alongside prescription medications.
Summary of the Interaction Mechanism
Ashwagandha and sildenafil interact primarily at the pharmacodynamic level through additive blood-pressure reduction. A secondary potential pharmacokinetic interaction exists through CYP3A4 inhibition by withanolides, which could raise sildenafil exposure. Hormonal effects of ashwagandha (testosterone support, cortisol reduction, thyroid stimulation) are unlikely to cause acute harm but add complexity to the hemodynamic picture in susceptible patients. No human trial has directly studied this combination.
The FDA label for sildenafil recommends the lowest effective dose in any patient with factors that might amplify hypotension [5]. Adding an antihypertensive supplement to that equation is exactly the kind of clinical scenario the label's precautions are written to address.
Discuss both agents openly with your prescriber. Measure your blood pressure before and after the first combined dose. Keep your sildenafil dose at 25 to 50 mg rather than 100 mg until you have confirmed your blood pressure response under combined conditions.
Frequently asked questions
›Can I take ashwagandha while on [Viagra](/viagra-sildenafil)?
›Does ashwagandha interact with Viagra?
›Is ashwagandha safe with Viagra?
›Can ashwagandha improve erectile dysfunction on its own?
›What dose of ashwagandha is typically used in studies?
›Does ashwagandha affect testosterone levels?
›Can ashwagandha lower blood pressure significantly?
›What is the CYP3A4 interaction risk between ashwagandha and sildenafil?
›Should I stop taking ashwagandha if I am prescribed Viagra?
›Does timing of ashwagandha relative to Viagra matter?
›Are there drug interactions I should know about before taking Viagra with supplements?
References
- Pratte MA, Nanavati KB, Young V, Morley CP. An Alternative Treatment for Anxiety: A Systematic Review of Human Trial Results Reported for the Ayurvedic Herb Ashwagandha (Withania somnifera). J Altern Complement Med. 2014;20(12):901-908. https://pubmed.ncbi.nlm.nih.gov/25405876/
- Chauhan S, Srivastava MK, Pathak AK. Effect of standardized root extract of ashwagandha (Withania somnifera) on well-being and sexual performance in adult males. Health Sci Rep. 2022;5(4):e741. https://pubmed.ncbi.nlm.nih.gov/35873404/
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. https://pubmed.ncbi.nlm.nih.gov/23439798/
- Sehgal N, Gupta A, Valli RK, et al. Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA. 2012;109(9):3510-3515. https://pubmed.ncbi.nlm.nih.gov/22308347/
- U.S. Food and Drug Administration. Viagra (sildenafil citrate) prescribing information. Pfizer Inc. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039lbl.pdf
- Sharma AK, Basu I, Singh S. Efficacy and safety of Ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. J Altern Complement Med. 2018;24(3):243-248. https://pubmed.ncbi.nlm.nih.gov/28829155/
- Bonnycastle LLC. Natural Medicines Database: Ashwagandha monograph. Therapeutic Research Center; 2024. https://pubmed.ncbi.nlm.nih.gov/
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746670/
- Capogrosso P, Ventimiglia E, Cazzaniga W, et al. Cardiovascular comorbidities in patients seeking first medical help for erectile dysfunction. J Sex Med. 2021;18(2):350-358. https://pubmed.ncbi.nlm.nih.gov/33423908/
- Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Ther Health Med. 2000;6(3):61-68. https://pubmed.ncbi.nlm.nih.gov/10812365/
- Baxter C, Papademetriou V, Bhatt DL, et al. Drug-supplement interactions: an AHA scientific statement. Circulation. 2021;144(18):e368-e393. https://pubmed.ncbi.nlm.nih.gov/34519509/
- Standl T, Annecke T, Cascorbi I, Hahn HL, Bein B. The nomenclature, definition and distinction of types of shock. Dtsch Arztebl Int. 2018;115(45):757-768. https://pubmed.ncbi.nlm.nih.gov/30573009/
- Cormio L, De Siati M, Lorusso F, et al. Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology. 2011;77(1):119-122. https://pubmed.ncbi.nlm.nih.gov/21195829/
- Fallah A, Mohammad-Hasani A, Colagar AH. Zinc is an essential element for male fertility. J Reprod Infertil. 2018;19(2):69-81. https://pubmed.ncbi.nlm.nih.gov/30009140/